Home / Tirzepatide
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Agonist at both the GIP and GLP-1 receptors, a mechanism distinct from single-receptor GLP-1 agonists such as semaglutide.
Reference only. This page covers what the compound is, how it is presented and how it is handled. It does not give dosing protocols or administration schedules, and it is not medical advice.
Class and mechanism
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Agonist at both the GIP and GLP-1 receptors, a mechanism distinct from single-receptor GLP-1 agonists such as semaglutide.
How it is supplied
Tirzepatide is supplied as a lyophilised vial or pre-filled pen. Reported half-life: Approximately five days in published pharmacokinetics. Storage: Refrigerated, protected from light. Not to be frozen.
| Listing | Strength | Price | Cost per mg | Stock |
|---|---|---|---|---|
| Quanta Pharma Tirzepatide 30mg + Free BW | 30 mg | £110 | £3.67 per mg | in stock |
| SerenQ Tirzepatide | - | £175 | - | in stock |
| Quanta Pharma Tirzepatide 60mg + Free BW | 60 mg | £185 | £3.08 per mg | in stock |
| VLS Tirzepatide Pen | - | £185 | - | in stock |
Stocked at The PED Shop
Quanta Pharma Tirzepatide 30mg + Free BWin stock£110- SerenQ Tirzepatidein stock£175
Quanta Pharma Tirzepatide 60mg + Free BWin stock£185
VLS Tirzepatide Penin stock£185
Availability checked 2026-09-08. The product page carries live stock.